Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

S. Petta, G. Cabibbo, M. Barbara, S. Attardo, L. Bucci, F. Farinati, E. G. Giannini, F. Tovoli, F. Ciccarese, G. L. Rapaccini, M. Di Marco, E. Caturelli, M. Zoli, F. Borzio, R. Sacco, R. Virdone, F. Marra, M. Felder, F. Morisco, L. BenvegnùAntonio Gasbarrini, G. Svegliati-Baroni, F. G. Foschi, A. Olivani, A. Masotto, G. Nardone, A. Colecchia, M. Persico, V. Boccaccio, A. Craxì, S. Bruno, F. Trevisani, C Cammà*, Maurizio Biselli, Paolo Caraceni, Alessandro Cucchetti, Marco Domenicali, Fabio Piscaglia, Annagiulia Gramenzi, Alessandro Granito, Donatella Magalotti, Carla Serra, Giulia Negrini, L. Napoli, Lucia Napoli, Veronica Salvatore, Francesca Benevento, Alessia Gazzola, Francesca Murer, Caterina Pozzan, Veronica Vanin, Alessandro Moscatelli, Gaia Pellegatta, Antonino Picciotto, Vincenzo Savarino, Paolo Delpoggio, Stefano Olmi, Nicoletta De Matthaeis, Claudia Balsamo, Elena Vavassori, Paola Roselli, Serena Dell’Isola, Anna Maria Ialungo, Elena Rastrelli, Francesca Rini, Andrea Costantino, Andrea Affronti, Marco Affronti, Marta Mascari, Andrea Mega, Maurizio Pompili, Emanuele Rinninella, Valeria Mismas, Anna Chiara Dall’Aglio, Valentina Feletti, Arianna Lanzi, Federica Mirici Cappa, Elga Neri, Giuseppe Francesco Stefanini, Stefano Tamberi, Elisabetta Biasini, Gabriele Missale, Maria Guarino, Alessio Ortolani, Maria Chiaramonte, Fabiana Marchetti, Matteo Valerio, Sami Aburas, Andrea L. Inghilesi, Alberta Cappelli, Rita Golfieri, Cristina Mosconi, Matteo Renzulli, Piero Coccoli, Marco Sanduzzi Zamparelli, Salvatore Petta, Giuseppe Cabibbo, Marco Barbara, Simona Attardo, Laura Bucci, Fabio Farinati, Edoardo G. Giannini, Francesco Tovoli, Francesca Ciccarese, Gian Lodovico Rapaccini, Maria Dimarco, Eugenio Caturelli, Marco Zoli, Franco Borzio, Rodolfo Sacco, Roberto Virdone, Fabio Marra, Martina Felder, Filomena Morisco, Luisa Benvegnù, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Andrea Olivani, Alberto Masotto, Gerardo Nardone, Antonio Colecchia, Marcello Persico, Vincenzo Boccaccio, Antonio Craxì, Savino Bruno, Franco Trevisani, Calogero Cammà*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

57 Citazioni (Scopus)

Abstract

Background: In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma (HCC), the time to HCC recurrence and the effects of sustained viral eradication (SVR) by interferon (IFN)-based or IFN-free regimens on HCC recurrence remain unclear. Aim: To perform an indirect comparison of time to recurrence (TTR) in patients with successfully treated early HCC and active HCV infection with those of patients with SVR by IFN-based and by IFN-free regimens. Methods: We evaluated 443 patients with HCV-related cirrhosis and Barcelona Clinic Liver Cancer Stage A/0 HCC who had a complete radiological response after curative resection or ablation. Active HCV infection was present in 328, selected from the Italian Liver Cancer group cohort; 58 patients had SVR achieved by IFN-free regimens after HCC cure, and 57 patients had SVR achieved by IFN-based regimens after HCC cure. Individual data of patients in the last two groups were extracted from available publications. Results: TTR by Kaplan–Meier curve was significantly lower in patients with active HCV infection compared with those with SVR both by IFN-free (P = 0.02) and by IFN-based (P < 0.001) treatments. TTR was similar in patients with SVR by IFN-free or by IFN-based (P = 0.49) strategies. Conclusion: In HCV-infected, successfully treated patients with early HCC, SVR obtained by IFN-based or IFN-free regimens significantly reduce tumour recurrence without differences related to the anti-viral strategy used.
Lingua originaleInglese
pagine (da-a)160-168
Numero di pagine9
RivistaAlimentary Pharmacology and Therapeutics
Volume45
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - 2017

All Science Journal Classification (ASJC) codes

  • Epatologia
  • Gastroenterologia
  • Farmacologia (medica)

Keywords

  • Pharmacology (medical)

Fingerprint

Entra nei temi di ricerca di 'Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon'. Insieme formano una fingerprint unica.

Cita questo